QR-kod

Current insights into monitoring of congenital adrenal hyperplasia

The management of 21-hydroxylase deficiency (21OHD), the most common form of congenital adrenal hyperplasia, remains challenging as both over- and undertreatment with hormone replacement therapy are associated with short and long-term complications. Monitoring of treatment efficacy typically combine...

Full beskrivning

Sparad:
Huvudupphov: Quinty M. Leusink, Elke E. W. Verploegen, Bas P. H. Adriaansen, Xinyi Chin, Nike M. M. L. Stikkelbroeck, Paul N. Span, Fred C. G. J. Sweep, Margo Dona, Antonius E. van Herwaarden, Hedi L. Claahsen-van der Grinten
Materialtyp: Artigo
Språk:Inglês
Utgiven: Frontiers Media S.A. 2026-02-01
Serie:Frontiers in Endocrinology
Ämnen:
congenital adrenal hyperplasia (CAH)
21-hydroxylase deficiency (21OHD)
monitoring
biomarkers
reference intervals
Länkar:https://www.frontiersin.org/articles/10.3389/fendo.2026.1774145/full
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk